Centrum Wsparcia Badań Klinicznych w 4.Wojskowym Szpitalu Klinicznym z Polikliniką we Wrocławiu

What Centrum Wsparcia Badań Klinicznych w 4.Wojskowym Szpitalu Klinicznym z Polikliniką we Wrocławiu does

Centrum Wsparcia Badań Klinicznych (CWBK) is a clinical research support center established in August 2021 within the 4th Military Clinical Hospital with Policlinic in Wrocław, Poland. It operates as a state-owned public healthcare entity (SP ZOZ) under the Polish Ministry of National Defense, with a multidisciplinary team of 12 specialists supporting both commercial clinical trials and non-commercial research across cardiology, nephrology, ophthalmology, oncology, rheumatology, and pulmonology. The center is funded primarily through an 8,530,437.48 PLN grant from the Polish Medical Research Agency (ABM) covering the period 01.08.2021 – 31.07.2026, supplemented by commercial trial contracts and participation in non-commercial research projects including Printgraft 3D, ProtectAA, GENTLE-PACE, and Notice-CAS.

The center serves pharmaceutical sponsors, contract research organizations (CROs), and academic researchers requiring clinical trial infrastructure, regulatory compliance, and patient recruitment capability within a Polish military hospital setting. Its core operational asset is the Regional Digital Medicine Center (RCMC), which provides biostatistics, data integration, biobanking, and data science services, leveraging the parent hospital's patient base of approximately 60,000 inpatients and 200,000 outpatient consultations annually. The CWBK holds ISO 9001 and ISO 27001 certifications, and is a designated member of the Polish Clinical Research Network (PSBK), one of 23 national centers.

The business model is hybrid: public grant funding through ABM constitutes the primary disclosed revenue stream, while commercial clinical trial fees, non-commercial research support contracts, and emerging data services through the RCMC provide additional but not separately quantified income. Distribution is driven by direct sponsor and CRO relationships, network-level referral through PSBK, and academic partnerships including a cooperation agreement with Wrocław University of Science and Technology signed in June 2026.

Name

Centrum Wsparcia Badań Klinicznych w 4.Wojskowym Szpitalu Klinicznym z Polikliniką we Wrocławiu

Legal name

4 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej

Website

https://4wsk.pl

Company type

Public

Founded year

1944

Operating status

Operating

Headcount range

11–50 employees

Short description

The Centrum Wsparcia Badań Klinicznych (CWBK) is a Polish state-owned clinical research support center within the 4th Military Clinical Hospital in Wrocław, established in 2021 to coordinate commercial and non-commercial clinical trials across six therapeutic areas for pharmaceutical sponsors, CROs, and academic researchers, funded primarily by an ABM grant and operating a digital medicine center.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGACAG

Clinical Trial Monitoring Support (On-site/Remote)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLACAOAI

Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management

Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

SECONDARYHLAGACAM

Clinical Trial Financial Management & Payments (Site Budgeting)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAF

Investigator & Site Training / GCP Support

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

Keywords

• Clinical trial services
• Clinical research support
• Contract research organization
• Clinical study coordination
• Investigator-initiated trials

Headquarters

HQ city

Wrocław

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Government grant funding (Agencja Badań Medycznych): CWBK is funded by a government grant from the Medical Research Agency (ABM) under competition ABM/2021/4. Total funding: 8,530,437.48 PLN for the period 01.08.2021 – 31.07.2026 (Project nr 2021/ABM/04/00008/P/05). This covers operational costs of the center.
2. Commercial clinical trial contracts: CWBK generates revenue by conducting commercial (sponsor-initiated) clinical trials for pharmaceutical companies and CROs. Services include feasibility, contracting, coordination, monitoring, and invoicing for clinical studies in cardiology, nephrology, ophthalmology, oncology, rheumatology, and pulmonology.
3. Non-commercial research support services: CWBK provides administrative and scientific coordination services for investigator-initiated (non-commercial) clinical trials, including support for ABM grant applications, bioethics committee submissions, budget development, and financial settlement of research projects.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

CWBK is a dedicated clinical research support center providing administrative, contracting, coordination, and monitoring services for both commercial (sponsor-initiated) and non-commercial (investigator-initiated) clinical trials across cardiology, nephrology, ophthalmology, oncology, rheumatology, and pulmonology. Its services span feasibility assessment, study contracting, trial coordination, clinical trial monitoring, pharmacy management, safety monitoring, financial settlement, and bioethics submissions, supplemented by the Regional Digital Medicine Center (RCMC) for biostatistics, data integration, data science, biobanking, and bioinformatics.

Product overview

CWBK is a clinical research support center established within the 4th Military Clinical Hospital with Polyclinic, funded by the Medical Research Agency (Agencja Badań Medycznych). The center provides a unified platform for clinical trial support services, comprising dedicated facilities with fully equipped medical and procedure rooms, quality management systems, and a pharmacy unit. The core offering includes both commercial and non-commercial clinical research support, supplemented by the Regional Digital Medicine Center (RCMC) which provides biostatistics, data science, biobanking, and bioinformatics capabilities. The center operates in cardiology, nephrology, ophthalmology, oncology, rheumatology, and pulmonology therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

• Centrum Wsparcia Badań Klinicznych (CWBK) Clinical Research Services A dedicated clinical research support center providing infrastructure, administrative support, and coordination services for commercial and non-commercial clinical trials in cardiology, nephrology, ophthalmology, oncology, rheumatology, and pulmonology. Serves pharmaceutical sponsors, CROs, and clinical investigators.
• Commercial Clinical Research (Badania Komercyjne) End-to-end support for sponsor-initiated commercial clinical trials conducted by pharmaceutical companies and CROs, including feasibility assessment, contracting, study coordination, monitoring, invoicing, and quality assurance.
• Non-Commercial Clinical Research (Badania Niekomercyjne) Support services for investigator-initiated (non-commercial) clinical trials and experiments, including bioethics committee applications, budget development, clinical trial design support, Medical Research Agency (ABM) grant application support, and financial settlement of research projects.
• Regionalne Centrum Medycyny Cyfrowej (RCMC) Digital Medicine Services Digital medicine center providing biostatistics, data integration, data science, bioinformatics, biobanking, and clinical research data system development services to support clinical trials within the center and across the network.

Quantifiable outcome

• Goal to contract new clinical trials within 60 days

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Five partnerships are on record, tiered major, moderate and core.

• GENTLE-PACE Study consortium partnersmajorStrategic or Co-development Partner · 1 January 2023The GENTLE-PACE Study (2023/ABM/01/000003-00) is conducted by a consortium led by 4WSK, in partnership with Śląski Uniwersytet Medyczny in Katowice and Mazowiecki Szpital Specjalistyczny in Radom.
• Politechnika Wrocławska (Wroclaw University of Science and Technology)moderateStrategic or Co-development Partner · 1 January 2023A cooperation agreement was signed on 25.06.2026 between the 4th Military Clinical Hospital and the Wroclaw University of Science and Technology. The hospital is a significant partner of the Faculty of Medicine established at the university in 2023.
• ProtectAA trial consortium partnersmajorStrategic or Co-development Partner · 1 January 2022The ProtectAA trial (2022/ABM/01/00039-00) is conducted by a consortium of three research teams: 4WSK (consortium leader, Heart Disease Center), Warsaw Military Medical Institute (cardiology and oncology), and the Breast Unit at Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii in Wrocław (oncology).
• Polska Sieć Badań Klinicznych (Polish Clinical Research Network, PSBK)coreStrategic or Co-development Partner · 1 August 2021CWBK is one of 23 centers in the PSBK, a national network established by ABM to ensure uniform standards for clinical trial conduct, high-quality patient service, and increased commercial and non-commercial clinical research in Poland. The network applies common management information standards and pricing models.
• Printgraft 3D consortium partnersmajorStrategic or Co-development Partner · 1 January 2020The Printgraft 3D project (2020/ABM/01/00121) is a multi-entity consortium led by Szpital Kliniczny Nr 2 PUM in Szczecin, with partners 4WSK (Vascular Surgery Department) and Szpital Kliniczny Przemienienia Pańskiego UM in Poznań.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• ICON plc: A leading global CRO with a substantial post-PRA Health footprint offering clinical trial services across all phases; competes for sponsor contracts at a broader international scale than CWBK with overlapping therapeutic area coverage.
• IQVIA: The largest global CRO offering full-service clinical trial management across all phases and geographies; competes with CWBK for sponsor contracts at much greater scale and broader portfolio, addressing the same customer need for trial execution in Poland.
• Syneos Health: A global biopharmaceutical services organization offering clinical and commercial services; overlaps with CWBK at the clinical trial execution layer for the same sponsors, but at significantly larger scale and broader geographic reach.
• Charles River Laboratories: A global CRO and preclinical services company with broad clinical trial capabilities; serves overlapping sponsors with a wider portfolio, competing indirectly for trial execution work that CWBK targets in Poland.

Direct peers

• Warszawski Instytut Medyczny (Warsaw Military Medical Institute): A Polish military-affiliated medical institute partnering with CWBK on the ProtectAA trial; operates a directly comparable clinical research model within a military hospital setting, addressing the same sponsor base in cardiology and oncology.
• Śląski Uniwersytet Medyczny w Katowicach: A Polish medical university participating in the GENTLE-PACE consortium with CWBK, with comparable academic clinical research capabilities and similar sponsor/CRO customer base across multiple therapeutic areas.
• Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii: A regional Wrocław oncology and pulmonology center partnering with CWBK on the ProtectAA trial; operates comparable clinical research infrastructure in overlapping therapeutic areas within the same city, competing for similar sponsor protocols.
• Mazowiecki Szpital Specjalistyczny w Radomiu: A Polish specialist hospital that is a GENTLE-PACE consortium partner with CWBK and runs its own clinical research program; comparable as a fellow Polish public clinical research site serving similar sponsor/CRO customers with overlapping trial coordination services.
• Szpital Kliniczny Nr 2 PUM w Szczecinie: A Polish clinical hospital leading the Printgraft 3D consortium with CWBK and operating clinical research infrastructure comparable to CWBK, serving the same Polish academic/sponsor ecosystem with multi-specialty trial capabilities.

Regional players

• ECRIN (European Clinical Research Infrastructure Network): A pan-European clinical research infrastructure network supporting multinational trial coordination across European academic sites; comparable as a network-level peer for cross-border trial coordination, though operating at a supranational scale versus CWBK's domestic focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/centrum-wsparcia-bada%C5%84-klinicznych

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centrum Wsparcia Badań Klinicznych w 4.Wojskowym Szpitalu Klinicznym z Polikliniką we Wrocławiu